1 / 6

Adalimumab Market Market - Industry News, Applications and Trends!

Adalimumab, with a trade name of Humira and Exemptia, is an anti-TNF drug used for treating rheumatoid arthritis, psoriatic arthritis, Crohn’s disease, psoriasis and ulcerative colitis.<br>

roopaP
Download Presentation

Adalimumab Market Market - Industry News, Applications and Trends!

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Adalimumab Market Research Report Forecast to 2021 Published on – 06 February, 2017 | Number of pages : 165 Single User Price: $ 2850 “Adalimumab Market”

  2. Adalimumab, with a trade name of Humira and Exemptia, is an anti-TNF drug used for treating rheumatoid arthritis, psoriatic arthritis, Crohn’s disease, psoriasis and ulcerative colitis. Adalimumab usually binds with tumor necrosis factor-alpha (TNFα). When a TNFα binds to a TBFα receptors, it results in an inflammatory response to autoimmune disease. Adalimumab, by binding to a TNFα, lowers the chances of inflammatory response.

  3. Adalimumab, which was first approved in the U.S., is currently being marketed in over 60 countries. Its global market is consolidated with a handful of players trying to outsmart one another on the basis of price. At present, most of the leading players are focused on the development of adalimumab biosimilars for curing rheumatoid arthritis and psoriasis. This is palpable from the clinical trials being carried out to test the safety and efficacy of the adalimumab biosimilars in curing the medical conditions. CLICK HERE TO CHECK COMPLETE REPORT

  4. Adalimumab Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). AVAIL MORE INFORMATION FROM SAMPLE BROCHURE OF REPORT

  5. About Us: MarketIntelReports (MIR) aim to empower our clients to successfully manage and outperform in their business decisions, we do this by providing Premium Market Intelligence, Strategic Insights and Databases from a range of Global Publishers. MIR intends to be a one-stop shop with an intuitive design, exhaustive database, expert assistance, secure cart checkout and data privacy integrated ensure that the database is constantly updated to dynamically meet the targeted, specific needs of our clients. MarketIntelReports currently has more than 10,000 plus titles and 35+ publishers on our platform and growing consistently to fill the “Adalimumab Market”. MAKE A ENQUIRY BEFORE BUYING

  6. Global Adalimumab Market Research Report-2021 A detailed qualitative analysis of the factors responsible for driving and restraining growth of “Global Adalimumab Market Research Report-2021” and future opportunities are provided in the report. Contact: 1-302-261-5343 pr@marketintelreports.com www.marketintelreports.com CLICK HERE TO PROCURE THIS REPORT

More Related